TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/24 20:58 | 4/1/24 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | EVP,CTO | S | -27 | 10.05 | 0 | -3 | -2 | 132 | D | ||||||||||||||
2/26/24 19:34 | 2/22/24 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | EVP,CTO | S.d | -124 | 10.05 | 0 | -12 | -8 | 135 | D | ||||||||||||||
3/31/23 14:40 | 3/30/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | CTO | S | -60 | 22.77 | 0 | -3 | -2 | 115 | D | ||||||||||||||
2/24/23 20:35 | 2/23/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | CTO | S.d | -60 | 25.97 | 0 | -2 | -2 | 117 | D | ||||||||||||||
3/31/22 14:46 | 3/30/22 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | CTO | S | -69 | 26.24 | 0 | -3 | -3 | 81 | D | ||||||||||||||
12/1/21 20:20 | 11/29/21 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hanly Ann M. | CA | O | CTO | P | 1 | 43.39 | 0 | 0 | 0 | 31 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |